News
- Kindred Biosciences Initiates Pivotal Efficacy Study of Tirnovetmab (Interleukin-31) Monoclonal Antibody for Canine Atopic DermatitisDecember 22, 2020 8:31 AM EST
- Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study for Anti-TNFα Antibody for Canine Inflammatory Bowel DiseaseDecember 21, 2020 8:31 AM EST
- Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights for its Parvovirus Monoclonal AntibodyDecember 11, 2020 8:00 AM EST
Events
- Monday, December 7, 2020 10:00 AM EST
- Thursday, November 19, 2020
- Tuesday, November 17, 2020 from 2:40 PM to 3:10 PM EST
|
KindredBio proudly supports
Rabies Free Africa
SEC Filings
Keyword Search
Report of unscheduled material events or corporate event
Statement of changes in beneficial ownership of securities
Report of unscheduled material events or corporate event
Report of unscheduled material events or corporate event
Quarterly report which provides a continuing view of a company's financial position
Statement of changes in beneficial ownership of securities
Securities offered to employees pursuant to employee benefit plans
Statement of changes in beneficial ownership of securities
Report of unscheduled material events or corporate event
Report of unscheduled material events or corporate event
Data provided by Kaleidoscope.